A Flagship VentureLabs Company

Adnexus Therapeutics
  

Adnexus Therapeutics

Initial Investment: 
2002
Status: 
Acquired

Adnexus Therapeutics was acquired by Bristol-Myers Squibb Company (NYSE: BMY) in 2007.